scholarly article | Q13442814 |
P356 | DOI | 10.1016/0042-6822(91)90465-N |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:004268229190465N?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:004268229190465N?httpAccept=text/xml | ||
P698 | PubMed publication ID | 1704654 |
P2093 | author name string | W. S. Robinson | |
S. Yuasa | |||
Q. Pham | |||
P. L. Marion | |||
R. C. Cheung | |||
P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase | Q26778389 | ||
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors | Q26778475 | ||
A simple method for displaying the hydropathic character of a protein | Q26778481 | ||
Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus. | Q35141530 | ||
Predicted secondary structure similarity in the absence of primary amino acid sequence homology: hepatitis B virus open reading frames | Q36259946 | ||
Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein | Q36802452 | ||
Identification and localization of pre-s-encoded polypeptides from woodchuck and ground squirrel hepatitis viruses | Q36855836 | ||
Characterization of a pre-S polypeptide on the surfaces of infectious avian hepadnavirus particles | Q36887249 | ||
Identification of hepatitis B virus polypeptides encoded by the entire pre-s open reading frame | Q36902925 | ||
Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences | Q36913034 | ||
The molecular biology of the hepatitis B viruses | Q39511089 | ||
Molecular cloning and sequence analysis of duck hepatitis B virus genomes of a new variant isolated from Shanghai ducks | Q42643409 | ||
Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing | Q43715300 | ||
Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks | Q43774248 | ||
Identification of an attachment site for human liver plasma membranes on hepatitis B virus particles | Q44396308 | ||
Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus | Q45836434 | ||
Protective effect of a synthetic peptide comprising the complete preS2 region of the hepatitis B virus surface protein | Q45843535 | ||
Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective | Q45847063 | ||
Mutation rate of the hepadnavirus genome | Q58396490 | ||
The hepatitis B virus | Q59051957 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatitis B | Q6853 |
Hepatitis B virus | Q6844 | ||
P304 | page(s) | 14-21 | |
P577 | publication date | 1991-03-01 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide | |
P478 | volume | 181 |
Q36631092 | A cell surface protein that binds avian hepatitis B virus particles. |
Q24527304 | Carboxypeptidase D is an avian hepatitis B virus receptor |
Q35868031 | Characterization of a 120-Kilodalton pre-S-binding protein as a candidate duck hepatitis B virus receptor. |
Q36650162 | Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product |
Q40015431 | Dual topology of the large envelope protein of duck hepatitis B virus: determinants preventing pre-S translocation and glycosylation |
Q46007395 | Enhanced magnitude and breadth of neutralizing humoral response to a DNA vaccine targeting the DHBV envelope protein delivered by in vivo electroporation. |
Q39642388 | Enhancement of hepatitis B virus infection by noninfectious subviral particles. |
Q48103866 | Establishment of a yeast-based VLP platform for antigen presentation. |
Q40048570 | Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor. |
Q33855246 | Hepatitis B virus biology |
Q27318278 | Heterologous replacement of the supposed host determining region of avihepadnaviruses: high in vivo infectivity despite low infectivity for hepatocytes |
Q45413516 | Identification of T-cell epitopes associated with immunity within the surface protein of duck hepatitis B virus |
Q40677965 | Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection. |
Q84867941 | In vivo electroporation improves therapeutic potency of a DNA vaccine targeting hepadnaviral proteins |
Q43647008 | In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein |
Q35851099 | Interaction between duck hepatitis B virus and a 170-kilodalton cellular protein is mediated through a neutralizing epitope of the pre-S region and occurs during viral infection |
Q51473519 | Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. |
Q33642700 | Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction |
Q35876475 | Topology of the large envelope protein of duck hepatitis B virus suggests a mechanism for membrane translocation during particle morphogenesis. |
Q24563902 | Viral and cellular determinants involved in hepadnaviral entry |
Search more.